ICD-10-CM Billable Code

B58.82

Toxoplasma myositis

Clinical Classification Guidelines

Medical Intelligence & Overview

Toxoplasma myositis is a rare condition involving inflammation of the muscles caused by an infection with the parasite Toxoplasma gondii. While it is typically seen in individuals with weakened immune systems, anyone can potentially develop this condition. Recognizing its symptoms and understanding its causes are crucial for appropriate diagnosis and management.

Causes & Symptoms

Clinical Causes: Infection with the Toxoplasma gondii parasite, often transmitted through contaminated food or water. Exposure to infected cat feces, as cats are common carriers of the parasite. Consuming undercooked or contaminated meat, particularly pork, lamb, or venison. Vertical transmission from mother to fetus during pregnancy. Reactivation of a latent infection in immunocompromised individuals, such as those with HIV/AIDS or organ transplant recipients.

Key Symptoms: Muscle pain and tenderness, often localized in specific regions. Swelling or inflammation in affected muscles. Muscle weakness, which may impair movement. Fever and general malaise. Fatigue and exhaustion. Sometimes, symptoms may be mild or absent, especially in healthy individuals.

Diagnostic & Treatment

Diagnosis Path: Diagnosing toxoplasma myositis involves a combination of clinical evaluation and laboratory tests. Healthcare providers may order blood tests to detect antibodies against Toxoplasma gondii, indicating current or past infection. Imaging studies, such as MRI, can reveal muscle inflammation and help assess the extent of the condition. In certain cases, a muscle biopsy may be performed to identify the parasite directly within muscle tissue.

Treatment Protocols: Treatment for toxoplasma myositis typically includes antiparasitic medications, such as pyrimethamine coupled with sulfadiazine, often alongside folinic acid to reduce side effects. The choice and duration of therapy depend on the severity of symptoms and the patient's immune status. Supportive care, including rest and pain management, may also be recommended. Immunocompromised individuals may require additional interventions to bolster their immune response. Regular follow-up is essential to monitor recovery and prevent complications.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B58.82 a billable ICD-10 code?
Yes, B58.82 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B58.82?
Clinical documentation must specify the nature of Toxoplasma myositis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

myositis toxoplasma